Buy and Hold This Unstoppable Growth Stock for the Next Decade_老虎社区_美港股上老虎

Buy and Hold This Unstoppable Growth Stock for the Next Decade

Motley Fool2021-12-28

Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido? And that's the pitch for Trupanion (NASDAQ:TRUP), a health ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

144

Jypsy
·2021-12-28
👍
回复
2
举报
Smartypants1
·2021-12-28
I didn't know there was a big business in insuring pets, you learn something new everyday
回复
1
举报
BossBoss
·2021-12-28
Do your own homework & invest wisely
回复
3
举报
Bspn
·2021-12-28
Ok
回复
2
举报
Mhong
·2021-12-28
Like & comment
回复
4
举报
MrInvestor
·2021-12-28
Insuring pet...ok[Surprised]
回复
3
举报
收起
- Lena03:
  pls like
  2021-12-28
  回复
  举报
Hopehope赋予希望
·2021-12-28
Lemonade pet insurance loss ratio is higher. What sets them apart from Lemonade? This warrants further investigation
回复
12
举报
收起
- RudolfKennedy:
  Guess we all want see share price going up.
  2021-12-30
  回复
  举报
- RGsun:
  okay
  2021-12-28
  回复
  举报
- Toshies:
  noice
  2021-12-28
  回复
  举报
查看更多 2 条评论
ivy888
·2021-12-28
Like
回复
4
举报
收起
- kenong62:
  ok done
  2021-12-28
  回复
  举报
coolstuff
·2021-12-28
if u believe motley fool then u are fool!
回复
2
举报
收起
- ivy888:
  pk
  2021-12-28
  回复
  举报
koolgal
·2021-12-28
Trupanion is certainly an interesting stock. Who would think that there is big business to insure pets? I guess if you are a dog or cat lover then it would be applicable to you. Afterall dogs are our best friend. What I am hesitant about that it is not profitable yet. 🤔
回复
13
举报
收起
- koolgal:
  Thanks
  2021-12-28
  回复
  举报
- tig2021:
  ok
  2021-12-28
  回复
  举报
- koolgal:
  Yes being a cat lover you know it is important to insure your pet. I used to have a dog & vet fees are very expensive.
  2021-12-28
  回复
  举报
查看更多 2 条评论
JPHC
·2021-12-28
Is it wise to invest in low cap non profitable growth stock in 2022 with tapering and interest hike? Seriously, not for me. [Surprised]
回复
3
举报
NeM0ooo
·2021-12-28
[Spurting]
回复
2
举报
63031164
·2021-12-28
Good
回复
3
举报
收起
- AxlChoo:
  Very good
  2021-12-28
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2194770109?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-28 11:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2194770109","market":"us","top_or_hot":-1,"title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","media":"Motley Fool","content":"<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","article_id":"2194770109","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","pubTimestamp":1640663220,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"When it comes to raking in recurring revenue, this company is a king.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"购买并持有这支未来十年不可阻挡的成长型股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRUP":0.9},"content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":696666133,"gmtCreate":1640684518562,"gmtModify":1640684825723,"author":{"id":"3567239827558758","authorId":"3567239827558758","name":"Jypsy","avatar":"https://static.tigerbbs.com/66e331c670eb88443b88c6bdb76224cf","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3567239827558758","idStr":"3567239827558758"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696666133","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696660475,"gmtCreate":1640683714512,"gmtModify":1640685636207,"author":{"id":"4091946206428770","authorId":"4091946206428770","name":"Smartypants1","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4091946206428770","idStr":"4091946206428770"},"htmlText":"I didn't know there was a big business in insuring pets, you learn something new everyday&nbsp;","listText":"I didn't know there was a big business in insuring pets, you learn something new everyday&nbsp;","text":"I didn't know there was a big business in insuring pets, you learn something new everyday","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696660475","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696688436,"gmtCreate":1640682754661,"gmtModify":1640682773361,"author":{"id":"3580876358829077","authorId":"3580876358829077","name":"BossBoss","avatar":"https://static.tigerbbs.com/b2ebd21bfc3e2e2cd727e40dbfd87596","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3580876358829077","idStr":"3580876358829077"},"htmlText":"Do your own homework &amp; invest wisely&nbsp;","listText":"Do your own homework &amp; invest wisely&nbsp;","text":"Do your own homework & invest wisely","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696688436","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696616439,"gmtCreate":1640680407000,"gmtModify":1640680407706,"author":{"id":"3582502134655895","authorId":"3582502134655895","name":"Bspn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3582502134655895","idStr":"3582502134655895"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696616439","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696619984,"gmtCreate":1640679501516,"gmtModify":1640679502748,"author":{"id":"3578449123371823","authorId":"3578449123371823","name":"Mhong","avatar":"https://static.tigerbbs.com/f1110c90505cf18cc129130892c4dc2a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578449123371823","idStr":"3578449123371823"},"htmlText":"Like &amp; comment&nbsp;","listText":"Like &amp; comment&nbsp;","text":"Like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696619984","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696844910,"gmtCreate":1640671378431,"gmtModify":1640671378813,"author":{"id":"3586672191897597","authorId":"3586672191897597","name":"MrInvestor","avatar":"https://static.tigerbbs.com/40974a38cd623c0089adf8fd12d91591","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3586672191897597","idStr":"3586672191897597"},"htmlText":"Insuring pet...ok[Surprised]&nbsp;","listText":"Insuring pet...ok[Surprised]&nbsp;","text":"Insuring pet...ok[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696844910","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7126552,"gmtCreate":1640678263173,"gmtModify":1640678263289,"authorId":4101369401329210,"author":{"id":4101369401329210,"idStr":"4101369401329210","authorId":4101369401329210,"name":"Lena03","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696844910,"type":1,"supId":0,"prevId":0,"content":"pls like","text":"pls like","html":"pls like"}],"langContent":"CN"},{"id":696841857,"gmtCreate":1640670506508,"gmtModify":1640670506508,"author":{"id":"3563421686188310","authorId":"3563421686188310","name":"Hopehope赋予希望","avatar":"https://static.tigerbbs.com/9d9527ab7ac6557b84288abebb9ec540","vip":2,"crmLevel":9,"crmLevelSwitch":0,"authorIdStr":"3563421686188310","idStr":"3563421686188310"},"htmlText":"Lemonade pet insurance loss ratio is higher. What sets them apart from Lemonade? This warrants further investigation&nbsp;","listText":"Lemonade pet insurance loss ratio is higher. What sets them apart from Lemonade? This warrants further investigation&nbsp;","text":"Lemonade pet insurance loss ratio is higher. What sets them apart from Lemonade? This warrants further investigation","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/696841857","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7138141,"gmtCreate":1640824464468,"gmtModify":1640824464468,"authorId":9000000000000404,"author":{"id":9000000000000404,"idStr":"9000000000000404","authorId":9000000000000404,"name":"RudolfKennedy","avatar":"https://static.tigerbbs.com/4bf2f8692df593c0e58239fd56abf27c","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696841857,"type":1,"supId":0,"prevId":0,"content":"Guess we all want see share price going up.","text":"Guess we all want see share price going up.","html":"Guess we all want see share price going up."},{"id":7127125,"gmtCreate":1640685782973,"gmtModify":1640685783007,"authorId":3573441806388470,"author":{"id":3573441806388470,"idStr":"3573441806388470","authorId":3573441806388470,"name":"RGsun","avatar":"https://static.tigerbbs.com/e0f837845726564ce1e187eaa5186f5b","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696841857,"type":1,"supId":0,"prevId":0,"content":"<u>okay</u>","text":"<u>okay</u>","html":"<u>okay</u>"},{"id":7126897,"gmtCreate":1640683409795,"gmtModify":1640683409852,"authorId":3564347422498720,"author":{"id":3564347422498720,"idStr":"3564347422498720","authorId":3564347422498720,"name":"Toshies","avatar":"https://static.tigerbbs.com/b78bf2ffbcb3cb83e3785c8025b4cc54","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696841857,"type":1,"supId":0,"prevId":0,"content":"<u>noice</u>","text":"<u>noice</u>","html":"<u>noice</u>"},{"id":7126687,"gmtCreate":1640680808475,"gmtModify":1640680808576,"authorId":3571463229344698,"author":{"id":3571463229344698,"idStr":"3571463229344698","authorId":3571463229344698,"name":"WayneLo","avatar":"https://static.tigerbbs.com/14093ba883674abafbe66f8cf1adf5d3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696841857,"type":1,"supId":0,"prevId":0,"content":"<u>hmmm</u>","text":"<u>hmmm</u>","html":"<u>hmmm</u>"},{"id":7126565,"gmtCreate":1640678481190,"gmtModify":1640678481225,"authorId":3586451610703869,"author":{"id":3586451610703869,"idStr":"3586451610703869","authorId":3586451610703869,"name":"KH321","avatar":"https://static.tigerbbs.com/c1bb8bd7d6d5df5f9732871fe60999ea","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696841857,"type":1,"supId":0,"prevId":0,"content":"OK","text":"OK","html":"OK"}],"langContent":"CN"},{"id":696858102,"gmtCreate":1640668484616,"gmtModify":1640668992427,"author":{"id":"3579641974902127","authorId":"3579641974902127","name":"ivy888","avatar":"https://static.tigerbbs.com/10358949b7fc96b011ec29ca7fd9c9a4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3579641974902127","idStr":"3579641974902127"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696858102","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7126365,"gmtCreate":1640675659724,"gmtModify":1640675659829,"authorId":3574928367638029,"author":{"id":3574928367638029,"idStr":"3574928367638029","authorId":3574928367638029,"name":"kenong62","avatar":"https://static.tigerbbs.com/37fd00bd8cea11b8aa1aed6d9ddd9413","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696858102,"type":1,"supId":0,"prevId":0,"content":"ok done","text":"ok done","html":"ok done"}],"langContent":"CN"},{"id":696850814,"gmtCreate":1640667874911,"gmtModify":1640668290076,"author":{"id":"3575813982420697","authorId":"3575813982420697","name":"coolstuff","avatar":"https://static.tigerbbs.com/59416cd904d3254185c947646f5920b9","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575813982420697","idStr":"3575813982420697"},"htmlText":"if u believe motley fool then u are fool!","listText":"if u believe motley fool then u are fool!","text":"if u believe motley fool then u are fool!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696850814","repostId":2194770109,"repostType":2,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7125792,"gmtCreate":1640668490951,"gmtModify":1640668490987,"authorId":3579641974902127,"author":{"id":3579641974902127,"idStr":"3579641974902127","authorId":3579641974902127,"name":"ivy888","avatar":"https://static.tigerbbs.com/10358949b7fc96b011ec29ca7fd9c9a4","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696850814,"type":1,"supId":0,"prevId":0,"content":"pk","text":"pk","html":"pk"}],"langContent":"CN"},{"id":696827969,"gmtCreate":1640667614044,"gmtModify":1640667614044,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3559581955535845","idStr":"3559581955535845"},"htmlText":"Trupanion is certainly an interesting stock.&nbsp; Who would think that there is big business to insure pets?&nbsp; I guess if you are a dog or cat lover then it would be applicable to you.&nbsp; Afterall dogs are our best friend.&nbsp; What I am hesitant about that it is not profitable yet. 🤔","listText":"Trupanion is certainly an interesting stock.&nbsp; Who would think that there is big business to insure pets?&nbsp; I guess if you are a dog or cat lover then it would be applicable to you.&nbsp; Afterall dogs are our best friend.&nbsp; What I am hesitant about that it is not profitable yet. 🤔","text":"Trupanion is certainly an interesting stock. Who would think that there is big business to insure pets? I guess if you are a dog or cat lover then it would be applicable to you. Afterall dogs are our best friend. What I am hesitant about that it is not profitable yet. 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":8,"repostSize":0,"link":"https://laohu8.com/post/696827969","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7126740,"gmtCreate":1640681782400,"gmtModify":1640681782400,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696827969,"type":1,"supId":7126602,"prevId":0,"content":"Thanks","text":"Thanks","html":"Thanks"},{"id":7126602,"gmtCreate":1640678981848,"gmtModify":1640678981932,"authorId":3587008457873110,"author":{"id":3587008457873110,"idStr":"3587008457873110","authorId":3587008457873110,"name":"tig2021","avatar":"https://static.tigerbbs.com/86558e2c1be0fae967630b306994ef5a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696827969,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":7126283,"gmtCreate":1640674572153,"gmtModify":1640674572153,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696827969,"type":1,"supId":7126240,"prevId":0,"content":"Yes being a cat lover you know it is important to insure your pet.&nbsp; I used to have a dog &amp; vet fees are very expensive.","text":"Yes being a cat lover you know it is important to insure your pet.&nbsp; I used to have a dog &amp; vet fees are very expensive.","html":"Yes being a cat lover you know it is important to insure your pet.&nbsp; I used to have a dog &amp; vet fees are very expensive."},{"id":7126278,"gmtCreate":1640674488708,"gmtModify":1640674488708,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696827969,"type":1,"supId":7126248,"prevId":0,"content":"Yes that is true.&nbsp; Thanks for sharing","text":"Yes that is true.&nbsp; Thanks for sharing","html":"Yes that is true.&nbsp; Thanks for sharing"},{"id":7126277,"gmtCreate":1640674468498,"gmtModify":1640674468498,"authorId":3559581955535845,"author":{"id":3559581955535845,"idStr":"3559581955535845","authorId":3559581955535845,"name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696827969,"type":1,"supId":7126252,"prevId":0,"content":"Yes I agree. Thanks for sharing","text":"Yes I agree. Thanks for sharing","html":"Yes I agree. Thanks for sharing"}],"langContent":"CN"},{"id":696824062,"gmtCreate":1640667189916,"gmtModify":1640667190330,"author":{"id":"3560153673056412","authorId":"3560153673056412","name":"JPHC","avatar":"https://static.tigerbbs.com/983066cca30c768ccae9fa351386fdfe","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3560153673056412","idStr":"3560153673056412"},"htmlText":"Is it wise to invest in low cap non profitable growth stock in 2022 with tapering and interest hike? Seriously,&nbsp;not for me.&nbsp;[Surprised]&nbsp;","listText":"Is it wise to invest in low cap non profitable growth stock in 2022 with tapering and interest hike? Seriously,&nbsp;not for me.&nbsp;[Surprised]&nbsp;","text":"Is it wise to invest in low cap non profitable growth stock in 2022 with tapering and interest hike? Seriously, not for me. [Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696824062","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696822151,"gmtCreate":1640666757281,"gmtModify":1640666757448,"author":{"id":"4091976027440070","authorId":"4091976027440070","name":"NeM0ooo","avatar":"https://static.tigerbbs.com/fc945b6e362666c4cb11d3c9b09018e8","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4091976027440070","idStr":"4091976027440070"},"htmlText":"[Spurting]&nbsp;","listText":"[Spurting]&nbsp;","text":"[Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696822151","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":696869296,"gmtCreate":1640663843054,"gmtModify":1640663843392,"author":{"id":"3578176602660058","authorId":"3578176602660058","name":"63031164","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578176602660058","idStr":"3578176602660058"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696869296","repostId":2194770109,"repostType":4,"repost":{"id":"2194770109","pubTimestamp":1640663220,"share":"https://www.laohu8.com/m/news/2194770109?lang=&edition=full","pubTime":"2021-12-28 11:47","market":"us","language":"en","title":"Buy and Hold This Unstoppable Growth Stock for the Next Decade","url":"https://stock-news.laohu8.com/highlight/detail?id=2194770109","media":"Motley Fool","summary":"When it comes to raking in recurring revenue, this company is a king.","content":"<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?</p>\n<p>And that's the pitch for <b><a href=\"https://laohu8.com/S/TRUP\">Trupanion</a></b>&nbsp;(NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F658285%2Fvet-holds-dog.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>This stock is going places</h2>\n<p>The key factor in Trupanion's future prospects is that its business model is highly repeatable.&nbsp;As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.</p>\n<p>In more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.</p>\n<p>Over the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.</p>\n<p>In other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company <b>Chewy </b>announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.</p>\n<h2>There aren't many headwinds to worry about either</h2>\n<p>In keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.</p>\n<p>Its total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.</p>\n<p>The largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.</p>\n<p>In a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify.&nbsp;At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy and Hold This Unstoppable Growth Stock for the Next Decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy and Hold This Unstoppable Growth Stock for the Next Decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TRUP":"Trupanion","BK4162":"人寿与健康保险","BK4211":"区域性银行"},"source_url":"https://www.fool.com/investing/2021/12/27/buy-and-hold-this-unstoppable-growth-stock-for-the/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194770109","content_text":"Getting medical care is expensive regardless of the patient's species. People need health insurance for themselves, so why not for Fido?\nAnd that's the pitch for Trupanion (NASDAQ:TRUP), a health insurance company made just for pets. For growth investors who are looking for a stock to hold throughout its galloping ascent, Trupanion has a lot to offer. Let's analyze why.\nImage source: Getty Images.\nThis stock is going places\nThe key factor in Trupanion's future prospects is that its business model is highly repeatable. As with health insurance for humans, subscribers pay a monthly fee in exchange for coverage that reduces the out-of-pocket cost of veterinary care. After rendering care, veterinarians then bill the insurer for reimbursement for their costs. When everything goes according to plan, the company makes money by betting that, on average, pets will be happier and healthier far more frequently than they are sick or injured.\nIn more quantitative terms, 98.7% of enrolled pets remain enrolled each month, and the company estimates that it makes $63.30 in revenue and $8.29 in cash per month per pet. So, each additional subscriber means a significant amount of revenue down the line -- and as of the Q3 earnings report, the total number of enrolled pets has increased by 37% compared to the third quarter in 2020.\nOver the last three years, quarterly revenue has grown by nearly 120%, and with the ongoing rapid subscriber growth, it's easy to see how the good times could keep rolling. That's especially true when considering that the market for pet insurance in the U.S. is still largely untapped, with management citing research suggesting a penetration rate of only 1%.\nIn other words, there's more smooth sailing to come, since there aren't any powerful competitors anywhere on the horizon. And, with the online pet goods company Chewy announcing earlier this month that it would be teaming up with Trupanion to offer pet insurance to its customers. This is yet another growth driver on the radar for next year and beyond.\nThere aren't many headwinds to worry about either\nIn keeping with the success of its ongoing expansion into the pet insurance market, Trupanion doesn't have many issues that might give investors pause.\nIts total expenses as a percentage of quarterly revenue aren't rising sharply over time, and it is currently debtless. While consistently posting a profit remains a challenge, the company had some free cash flow (FCF) in 2019 and 2020 anyway. Although it is unprofitable, its net margin is within 5% of being positive, so it's entirely feasible for it to keep growing rapidly and worry about increasing efficiency once the market starts to get crowded.\nThe largest risk to shareholders may be dilution. Last year, Trupanion raised $192.3 million by issuing new stock, which was far more than it issued in the previous five years. Still, new stock hasn't been issued in 2021, and it might not be anytime soon. With more than $221.5 million in the bank, there's a long runway to figure out how to provide profitable coverage.\nIn a nutshell, this is a solid business that's very much in the window of opportunity for newcomers to invest. As a bonus, most investors probably don't have direct exposure to the pet health insurance market in their portfolios, so Trupanion could also be considered a great way to diversify. At the end of the day, buying this stock is a bet that people will continue to love their pets and look out for their pets' health. To me, that's a slam dunk.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7125430,"gmtCreate":1640664130902,"gmtModify":1640664131008,"authorId":3576321881416814,"author":{"id":3576321881416814,"idStr":"3576321881416814","authorId":3576321881416814,"name":"AxlChoo","avatar":"https://static.tigerbbs.com/07cda5bcab8b688f3844cf237bffa55f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":696869296,"type":1,"supId":0,"prevId":0,"content":"Very good","text":"Very good","html":"Very good"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":144,"commentSize":13,"repostSize":0,"favoriteSize":5,"likeStatus":false,"favoriteStatus":false}}